Min.Order / FOB Price:Get Latest Price
1 Kilogram |
Negotiable |
Terbinafine Hydrochloride 78628-80-5 C21H26ClN
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide Basic information |
Product Name: | iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
Synonyms: | iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide;IODOMETHYL PENICILLANATE 1,1-DIOXIDE;IODOPENICILLANIC ACID-1,1-DIOXIDE;(2S,5R)-3,3-Dimethyl-4,4,7-trioxo-4-thia(VI)-1-azabicyclo[3.2.0]heptane-2-carboxylic acid iodomethyl ester;(2S,5R)-iodoMethyl 3,3-diMethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide |
CAS: | 76247-39-7 |
MF: | C9H12INO5S |
MW: | 373.16475 |
EINECS: | 278-400-1 |
Product Categories: | |
Mol File: | 76247-39-7.mol |
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide Chemical Properties |
Safety Information |
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide Usage And Synthesis |
iodomethyl (2S-cis)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide Preparation Products And Raw materials |
Terbinafine Hydrochloride Basic information |
Dermatologist Broad-spectrum Antifungal Drugs Pharmacokinetics Indications Usage and Dosage Chemical Properties Usage |
Product Name: | Terbinafine Hydrochloride |
Synonyms: | (e)-n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethylaminehydroc;lamosil;n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethanamin(e)-1-naphthalenemethanaminmon;n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethanamin(e)-1-naphthalenemethanaminmonohydrochloride;TERBINAFINE HCL;N-[(2E)-6,6-DIMETHYL-2-HEPTEN-4-YNYL]-N-METHYL-1-NAPHTHALENEMETHANAMINE;TRANS-N-(6,6-DIMETHYL-2-HEPTEN-4-YNYL)-N-METHYL-1-NAPHTHYLMETHYLAMINE HYDROCHLORIDE;(e)-n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethanamine monohydrochloride |
CAS: | 78628-80-5 |
MF: | C21H26ClN |
MW: | 327.89 |
EINECS: | 245-385-8 |
Product Categories: | Antifungal;APIs;Acetylenes;Antifungals for Research and Experimental Use;Biochemistry;Functionalized Acetylenes;Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Terbinafine;LAMISIL |
Mol File: | 78628-80-5.mol |
Terbinafine Hydrochloride Chemical Properties |
mp | 204-208°C |
storage temp. | -20°C Freezer |
Merck | 9156 |
CAS DataBase Reference | 78628-80-5(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi,N |
Risk Statements | 36/37/38-50/53 |
Safety Statements | 26-36/37/39-61-60 |
RIDADR | UN 3077 9/PG 3 |
RTECS | QJ8600100 |
Terbinafine Hydrochloride Usage And Synthesis |
Dermatologist Broad-spectrum Antifungal Drugs |
Terbinafine hydrochloride is a kind of broad-spectrum dermatologist allyl amine antifungal drugs. It is developed by Swiss Novartis in the 1980 s, and appeared in the market of UK for the first time in 1991. Approved by FDA of the United States for OTC drugs in 1996, and appeared in the market of the United States in the same year. At present, the drug is been sold in more than 90 countries of the word. It can specificity trouble the late biological decomposition of fungus sterol, selectively inhibit the activity of fungal squalene ring oxidase, and inhibit the squalene epoxidation in the formation of ungal cell membrane, thus to kill or inhibit the active of the fungus. Suitable for treatment of candidiasis skin, such as tinea manuum, tinea, tinea, ringworm of the body, tinea versicolor, it is also the best medicine for the treatment of onychomycosis. Terbinafine hydrochloride entered the the first batch of country announced OTC directory in 2000. This product belongs to antifungal drugs. It has strong effect on shallow fungal infection, and can cure most of the fungal skin diseases through external use. |
Pharmacokinetics | According to reports in the literatures, after 250 mg of Terbinafine hydrochloride been taken orally, it reaches peak plasma concentration of 0.97 m ug/ml within 2 hours. The absorption half-life is 0.8 hours, spread half-life is 4.6 hours, the degree of biological application is slightly affected by eating, but not used for dose adjustments. The combination rate of drugs and plasma protein is 99%, and can quickly disperse and concentrate in the lipophilic corneous |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View